Literature DB >> 33664224

Novel molecular subgroups within the context of receptor tyrosine kinase and adhesion signalling in multiple myeloma.

Ellen Leich1, Martin Schreder2,3, Jordan Pischimarov4, Thorsten Stühmer5, Torsten Steinbrunn2, Martina Rudelius4,6, Daniela Brünnert5, Manik Chatterjee5, Christian Langer7, Sarah Keppler4, Sofia Catalina Heredia-Guerrero4, Hermann Einsele2, Stefan Knop2, Ralf Christian Bargou5, Andreas Rosenwald4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33664224      PMCID： PMC7933144          DOI： 10.1038/s41408-021-00442-2

Source DB:  PubMed          Journal:  Blood Cancer J        ISSN： 2044-5385            Impact factor:   11.037


× No keyword cloud information.
  14 in total

1.  Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013.

Authors:  Joseph R Mikhael; David Dingli; Vivek Roy; Craig B Reeder; Francis K Buadi; Suzanne R Hayman; Angela Dispenzieri; Rafael Fonseca; Taimur Sher; Robert A Kyle; Yi Lin; Stephen J Russell; Shaji Kumar; P Leif Bergsagel; Steven R Zeldenrust; Nelson Leung; Matthew T Drake; Prashant Kapoor; Stephen M Ansell; Thomas E Witzig; John A Lust; Robert J Dalton; Morie A Gertz; A Keith Stewart; Keith Stewart; S Vincent Rajkumar; Asher Chanan-Khan; Martha Q Lacy
Journal:  Mayo Clin Proc       Date:  2013-04       Impact factor: 7.616

2.  Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents.

Authors:  Saad Z Usmani; Christoph Heuck; Alan Mitchell; Jackie Szymonifka; Bijay Nair; Antje Hoering; Yazan Alsayed; Sarah Waheed; Sajjad Haider; Alejandro Restrepo; Frits Van Rhee; John Crowley; Bart Barlogie
Journal:  Haematologica       Date:  2012-06-11       Impact factor: 9.941

Review 3.  Multiple myeloma.

Authors:  Christoph Röllig; Stefan Knop; Martin Bornhäuser
Journal:  Lancet       Date:  2014-12-23       Impact factor: 79.321

Review 4.  Molecular pathogenesis of multiple myeloma: basic and clinical updates.

Authors:  Marta Chesi; P Leif Bergsagel
Journal:  Int J Hematol       Date:  2013-02-28       Impact factor: 2.490

5.  Myc protein overexpression is a feature of progression and adverse prognosis in multiple myeloma.

Authors:  Hanne E H Møller; Birgitte S Preiss; Per Pedersen; Brian Østergaard; Mikael Frederiksen; Niels Abildgaard; Michael B Møller
Journal:  Eur J Haematol       Date:  2018-07-12       Impact factor: 2.997

6.  Initial genome sequencing and analysis of multiple myeloma.

Authors:  Michael A Chapman; Michael S Lawrence; Jonathan J Keats; Kristian Cibulskis; Carrie Sougnez; Anna C Schinzel; Christina L Harview; Jean-Philippe Brunet; Gregory J Ahmann; Mazhar Adli; Kenneth C Anderson; Kristin G Ardlie; Daniel Auclair; Angela Baker; P Leif Bergsagel; Bradley E Bernstein; Yotam Drier; Rafael Fonseca; Stacey B Gabriel; Craig C Hofmeister; Sundar Jagannath; Andrzej J Jakubowiak; Amrita Krishnan; Joan Levy; Ted Liefeld; Sagar Lonial; Scott Mahan; Bunmi Mfuko; Stefano Monti; Louise M Perkins; Robb Onofrio; Trevor J Pugh; S Vincent Rajkumar; Alex H Ramos; David S Siegel; Andrey Sivachenko; A Keith Stewart; Suzanne Trudel; Ravi Vij; Douglas Voet; Wendy Winckler; Todd Zimmerman; John Carpten; Jeff Trent; William C Hahn; Levi A Garraway; Matthew Meyerson; Eric S Lander; Gad Getz; Todd R Golub
Journal:  Nature       Date:  2011-03-24       Impact factor: 49.962

7.  Rare SNPs in receptor tyrosine kinases are negative outcome predictors in multiple myeloma.

Authors:  Sarah Keppler; Susann Weiβbach; Christian Langer; Stefan Knop; Jordan Pischimarov; Miriam Kull; Thorsten Stühmer; Torsten Steinbrunn; Ralf Bargou; Hermann Einsele; Andreas Rosenwald; Ellen Leich
Journal:  Oncotarget       Date:  2016-06-21

Review 8.  The Impact of Tumor Heterogeneity on Diagnostics and Novel Therapeutic Strategies in Multiple Myeloma.

Authors:  Leo Rasche; K Martin Kortüm; Marc S Raab; Niels Weinhold
Journal:  Int J Mol Sci       Date:  2019-03-12       Impact factor: 5.923

9.  Multiple myeloma is affected by multiple and heterogeneous somatic mutations in adhesion- and receptor tyrosine kinase signaling molecules.

Authors:  E Leich; S Weißbach; H-U Klein; T Grieb; J Pischimarov; T Stühmer; M Chatterjee; T Steinbrunn; C Langer; M Eilers; S Knop; H Einsele; R Bargou; A Rosenwald
Journal:  Blood Cancer J       Date:  2013-02-08       Impact factor: 11.037

10.  A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis.

Authors:  Brian A Walker; Konstantinos Mavrommatis; Christopher P Wardell; T Cody Ashby; Michael Bauer; Faith Davies; Adam Rosenthal; Hongwei Wang; Pingping Qu; Antje Hoering; Mehmet Samur; Fadi Towfic; Maria Ortiz; Erin Flynt; Zhinuan Yu; Zhihong Yang; Dan Rozelle; John Obenauer; Matthew Trotter; Daniel Auclair; Jonathan Keats; Niccolo Bolli; Mariateresa Fulciniti; Raphael Szalat; Phillipe Moreau; Brian Durie; A Keith Stewart; Hartmut Goldschmidt; Marc S Raab; Hermann Einsele; Pieter Sonneveld; Jesus San Miguel; Sagar Lonial; Graham H Jackson; Kenneth C Anderson; Herve Avet-Loiseau; Nikhil Munshi; Anjan Thakurta; Gareth Morgan
Journal:  Leukemia       Date:  2018-07-02       Impact factor: 11.528
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.